Novo Nordisk Grabs Shark Antibody-Based CNS Delivery Technology From Ossianix

 
• By John Davis
  
Trojan horse
The technology is a "Trojan Horse" approach to CNS drug delivery. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business